Gts Securities »

Neurosense Therapeutics shares owned by Gts Securities

Quarter-by-quarter ownership of Neurosense Therapeutics (NRSN) shares owned by Gts Securities from 13F filings

Historical chart of Gts Securities investment in Neurosense Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Neurosense Therapeutics held by Gts Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurosense Therapeutics by Gts Securities

Quarter filed Position value Share count Share price at filing
2025-12-31 $28k 36k 0.77

More positions owned by Gts Securities

Entrepreneurshares Series Tr Ershares Private (XOVR)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Apple (AAPL)
Meta Platforms Cl A (META)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Russell 2000 Etf (IWM)
Broadcom (AVGO)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Ishares Tr Msci India Etf (INDA)
Netflix (NFLX)
Select Sector Spdr Tr State Street Tec (XLK)
Ishares Tr China Lg-cap Etf (FXI)

View all positions for Gts Securities

Top funds holding Neurosense Therapeutics

Yorkville Advisors Global
Meitav Dash Investments
Gts Securities
UBS Group
Commonwealth Equity Services
Two Sigma Investments
Squarepoint Ops
Pathstone Holdings
Geode Capital Management
Creative Planning
SBI Securities
Jones Financial Companies, L.L
Jessup Wealth Management

View all funds holding Neurosense Therapeutics